Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 5;73(11):215.
doi: 10.1007/s00262-024-03805-3.

Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers

Affiliations

Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers

Jung Ho Kim et al. Cancer Immunol Immunother. .

Abstract

The detailed association between tumor DNA methylation, including CpG island methylation, and tumor immunity is poorly understood. CpG island methylator phenotype (CIMP) is observed typically in sporadic colorectal cancers (CRCs) with microsatellite instability-high (MSI-H). Here, we investigated the differential features of the tumor immune microenvironment according to CIMP status in MSI-H CRCs. CIMP-high (CIMP-H) or CIMP-low/negative (CIMP-L/0) status was determined using MethyLight assay in 133 MSI-H CRCs. All MSI-H CRCs were subjected to digital pathology-based quantification of CD3 + /CD8 + /CD4 + /FoxP3 + /CD68 + /CD204 + /CD177 + tumor-infiltrating immune cells using whole-slide immunohistochemistry. Programmed death-ligand 1 (PD-L1) immunohistochemistry was evaluated using the tumor proportion score (TPS) and combined positive score (CPS). Representative cases were analyzed using whole-exome and RNA-sequencing. In 133 MSI-H CRCs, significantly higher densities of CD8 + tumor-infiltrating lymphocytes (TILs) were observed in CIMP-H tumors compared with CIMP-L/0 tumors. PD-L1 TPS and CPS in CIMP-H tumors were higher than in CIMP-L/0 tumors. Next-generation sequencing revealed that, compared with CIMP-L/0 tumors, CIMP-H tumors had higher fractions of CD8 + T cells/cytotoxic lymphocytes, higher cytolytic activity scores, and activated immune-mediated cell killing pathways. In contrast to CIMP-L/0 tumors, most CIMP-H tumors were identified as consensus molecular subtype 1, an immunogenic transcriptomic subtype of CRC. However, there were no differences in tumor mutational burden (TMB) between CIMP-H and CIMP-L/0 tumors in MSI-H CRCs. In conclusion, CIMP-H is associated with abundant cytotoxic CD8 + TILs and PD-L1 overexpression independent of TMB in MSI-H CRCs, suggesting that CIMP-H tumors represent a typical immune-hot subtype and are optimal candidates for immunotherapy in MSI-H tumors.

Keywords: Colorectal carcinoma; CpG Island methylation; DNA methylation; Microsatellite instability; Mismatch repair; Tumor immunology.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

Figures

Fig. 1
Fig. 1
Comparison of pathology-based TIME features between CIMP subgroups of MSI-H CRCs. a Comparison of CD8+ TIL densities between CIMP-H and CIMP-L/0 subgroups of MSI-H CRCs at IM (left) and CT (right) areas. b Representative photomicrographs of CD8 IHC in CIMP-H and CIMP-L/0 MSI-H CRCs. Note the higher density of CD8+ TILs in the CIMP-H tumor, compared with the CIMP-L/0 tumor (scale bar, 200 μm). c Comparison of PD-L1 IHC scores, including TPS (left) and CPS (right), between CIMP-H and CIMP-L/0 subgroups of MSI-H CRCs. d Representative photomicrographs of PD-L1 IHC in CIMP-H and CIMP-L/0 MSI-H CRCs. Note the diffuse strong expression pattern of PD-L1 in the CIMP-H tumor, compared with the CIMP-L/0 tumor (scale bar, 100 μm). Abbreviations: TIME, tumor immune microenvironment; CIMP, CpG island methylator phenotype; CIMP-H, CIMP-high; CIMP-L/0, CIMP-low/negative; MSI-H, microsatellite instability-high; CRCs, colorectal cancers; TIL, tumor-infiltrating lymphocyte; IM, invasive margin; CT, center of tumor
Fig. 2
Fig. 2
Comparison of transcriptome-based immuno-molecular features between CIMP subgroups of MSI-H CRCs. a Comparison of immune cell types and immune-related scores between CIMP-H and CIMP-L/0 subgroups of MSI-H CRCs. The combined p-value is computed using the Fisher method. Colors indicate significance and enrichment: Red signifies significantly enriched cell types and scores in CIMP-H tumors, while blue signifies significantly enriched cell types and scores in CIMP-L/0 tumors. Gray indicates insignificant cell types and scores. b Comparison of cytolytic activity scores between CIMP-H and CIMP-L/0 subgroups of MSI-H CRCs. c Comparison of frequencies of CMS1 between CIMP-H and CIMP-L/0 subgroups of MSI-H CRCs. d GSEA-based comparison of 50 cancer hallmarks between CIMP-H and CIMP-L/0 subgroups of MSI-H CRCs. The dot size corresponds to the gene counts associated with gene ontology terms, while the color gradient from purple to red indicates the adjusted p-value. e GSEA-based comparison of biological process terms between CIMP-H and CIMP-L/0 subgroups of MSI-H CRCs. Abbreviations: CIMP, CpG island methylator phenotype; CIMP-H, CIMP-high; CIMP-L/0, CIMP-low/negative; MSI-H, microsatellite instability-high; CRCs, colorectal cancers; CMS1, consensus molecular subtype 1; GSEA, gene set enrichment analysis; DEG, differentially expressed gene; GO, gene ontology
Fig. 3
Fig. 3
Comparison of genomic features between CIMP subgroups of MSI-H CRCs. a Comparison of TMB between CIMP-H and CIMP-L/0 subgroups of MSI-H CRCs. b The mutational landscape comparison between CIMP-H and CIMP-L/0 subgroups of MSI-H CRCs. Genes include known major oncogenes or tumor suppressor genes in CRC. Alteration types were denoted by color and shape. Abbreviations: CIMP, CpG island methylator phenotype; CIMP-H, CIMP-high; CIMP-L/0, CIMP-low/negative; MSI-H, microsatellite instability-high; CRCs, colorectal cancers; TMB, tumor mutational burden; ns, not significant
Fig. 4
Fig. 4
Graphical summary of this study

Similar articles

Cited by

References

    1. Suzuki MM, Bird A (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9:465–476. 10.1038/nrg2341 - PubMed
    1. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427–5440. 10.1038/sj.onc.1205600 - PubMed
    1. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96:8681–8686. 10.1073/pnas.96.15.8681 - PMC - PubMed
    1. Hughes LA, Melotte V, de Schrijver J, de Maat M, Smit VT, Bovee JV et al (2013) The CpG island methylator phenotype: what’s in a name? Cancer Res 73:5858–5868. 10.1158/0008-5472.CAN-12-4306 - PubMed
    1. Ogino S, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ et al (2008) LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 122:2767–2773. 10.1002/ijc.23470 - PMC - PubMed

MeSH terms